nVerses Capital’s Labcorp LH Stock Holding History

nVerses Capital’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,074	Closed	-$553K	–	441
2026 Q1	$553K	Buy	+2,074	New	+$562K	0.5%	31

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

nVerses Capital's LH Position: Q2 2026 in Review

nVerses Capital sold out of Labcorp (LH) in Q2 2026, closing a stake of 2,074 shares — an estimated $553K sold.

nVerses Capital first reported a position in LH in Q1 2026 and held it in 1 quarter. The position peaked at $553K in Q1 2026. 871 funds tracked by Wall St. Rank hold LH as of Q2 2026.

nVerses Capital reported no remaining Labcorp position as of Q2 2026 after selling out during the quarter.
nVerses Capital sold 2,074 Labcorp shares in Q2 2026, an estimated $553K.
nVerses Capital first reported a position in Labcorp in Q1 2026 and held it in 1 quarter.
nVerses Capital's Labcorp position peaked at $553K in Q1 2026.
871 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.